Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Genetic Markers of Coronary Heart Disease (CROSBI ID 464267)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa

Stavljenić-Rukavina, Ana ; Sertić, Jadranka ; Salzer, Branka ; Zrinski, Renata ; Krajina, Andina Genetic Markers of Coronary Heart Disease // Proceedings of the XVI International Congress of Clinical Chemistry / Martin, Susan M. ; Halloran, Stephen P. (ur.). London : Delhi: The Association of Clinical Chemists, 1996. str. 232-233-x

Podaci o odgovornosti

Stavljenić-Rukavina, Ana ; Sertić, Jadranka ; Salzer, Branka ; Zrinski, Renata ; Krajina, Andina

engleski

Genetic Markers of Coronary Heart Disease

Coronary heart disease (CHD) is the main cause of death in the world. Among several inherent factors contributing to the development of atherosclerosis in CHD, abnormalities in lipid metabolism and hypertension probably play important, if not crucial, roles. Lipoprotein molecular markers Lp(a) and apo E together with newer candidates associated with CHD by unknown mechanisms such as angiotensin converting enzyme (ACE) polymorphism have been investigated to reach understanding of factors underlying the genetic basis of this multifactorial disorder. In this study, 50 patients with myocardial infarction were studied for apo E genotype, ACE gene typing and Lp(a) levels. The frequency of apo E genotypes due to allelic variation at amino acids 112 and 158 and ACE polymorphism were analysed by PCR technology. Lp(a) was quantified using rabbit antisera that were monospecific for the Lp(a) antigen. Results revealed 20% of the patients to be E4/4 homozygotes indicating an increased prevalence of E4/4 homozygosity as compared to control subjects (2%) and suggesting its probably atherogenic role in CHD. Results of ACE genotypes showed 42% of the study patients to be homozygous for the DD, 26% for II and 32% for ID allele. The frequency of the I and D alleles in patients was 0.42 and 0.58. The synthesis and metabolism of Lp(a) in the E4/4 genotype appears to shed some light upon the problem, suggesting an association between these two parameters.

coronary heart disease; genetic markers

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

232-233-x.

1996.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

Proceedings of the XVI International Congress of Clinical Chemistry

Martin, Susan M. ; Halloran, Stephen P.

London : Delhi: The Association of Clinical Chemists

Podaci o skupu

XVI. International Congress of Clinical Chemistry

poster

08.07.1996-12.07.1996

London, Ujedinjeno Kraljevstvo

Povezanost rada

Temeljne medicinske znanosti